According to new research, one protein can regulate the expression of a large number of genes that modulate pain.
Researchers have identified a mechanism that appears to be responsible for a rare form of pediatric neuropathy.
Researchers identify the role of the tumor suppressor Merlin in regulating the integrity of axons. Damage to the axons may result in peripheral neuropathy.
Intercepting CCL2 with specific antibodies may provide an early intervention for chronic neuropathic pain.
New findings suggest neuropathic pain could be prevented.
A new study reveals, in rodents, some spinal pain begins in the frontal cortex. Researchers say the findings could help in the development of new treatments for chronic pain.
Fluoroquinolone antibiotics, such as Levofloxacin and Ciprofloxacin, appear to increase the risk of peripheral neuropathy by 47%. However, there is no significant increased risk of developing neuropathy associated with amoxicillin use.
A mouse study reveals nerve cells damaged as a result of diabetes may not be repairable due to low levels of specific cytokines.
A new study reports prediabetes may be more damaging to motor nerves than previously believed.
KLS-13019, a novel CBD analog, shows promise at reversing pain sensitivity and preventing symptoms of neuropathy in mouse models of chemotherapy-induced peripheral neuropathy.
A new study reports transcranial alternating current stimulation could help treat chronic back pain. Researchers report tACs enhances alpha oscillations in the somatosensory cortex, reducing pain significantly.
A number of patients who contracted COVID-19 in the early months of the pandemic reported symptoms of neuropathy, including pain, tingling sensations, and numbness that lasted up to three months after recovery. The findings suggest COVID-19 may have lingering effects on peripheral nerves.
